Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Isabelle Sermet‐Gaudelus, Alexandra Pastor et al.|European Journal of Medicinal Chemistry|2021Cited by 67
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancerLaetitia Fend, Laurence Zitvogel, Christina Iribarren et al.|OncoImmunology|2016Cited by 39
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Isabelle Sermet‐Gaudelus, Saı̈k Urien et al.|Clinical Pharmacokinetics|2024Cited by 10